Actinium Pharmaceuticals, Inc. (ATNM) SEC Filings — 2025
6 SEC filings for Actinium Pharmaceuticals, Inc. (ATNM) in 2025.
Filings
- Actinium Pharmaceuticals Files 8-K on Officer/Director Changes — 8-K · Nov 26, 2025
- Actinium Narrows Q3 Loss by 56% on R&D, G&A Cuts — 10-Q · Nov 14, 2025
- Actinium Pharma Sets Annual Meeting for Key Director, Auditor Votes — DEF 14A · Nov 5, 2025
- Actinium Pharmaceuticals Reports No Revenue, Focuses on Iomab-B Phase 3 — 10-Q · Aug 8, 2025
- Actinium Pharmaceuticals Files Q1 2025 10-Q Report — 10-Q · May 9, 2025
- Actinium Pharmaceuticals Files 2024 Annual Report — 10-K · Mar 31, 2025